Wellington Management Group LLP Increases Stake in Revance Therapeutics, at Defense World
☀️Trending News Revance Therapeutics ($NASDAQ:RVNC), Inc. is a biotechnology company that focuses on the development and commercialization of innovative therapies [...]
Revance Therapeutics Intrinsic Value – Revance Therapeutics Showing Positive Returns According to New Trading Data
☀️Trending News Revance Therapeutics ($NASDAQ:RVNC) Inc is a biotechnology company focused on developing therapeutic treatments for the aesthetic and therapeutic [...]
REVANCE THERAPEUTICS Reports Third Quarter Earnings Results for Fiscal Year 2023
🌥️Earnings Overview On November 8, 2023, REVANCE THERAPEUTICS ($NASDAQ:RVNC) published their financial results for the third quarter of fiscal year [...]
REVANCE THERAPEUTICS Reports 95.7% Year-Over-Year Increase in Q3 FY2023 Revenue of USD 56.8 Million
☀️Earnings Overview On November 8, 2023, Revance Therapeutics ($NASDAQ:RVNC) released their financial results for the third quarter of FY2023, which [...]
Revance Therapeutics Stock Fair Value Calculation – Mizuho Sets $16.00 Price Target for Revance Therapeutics
🌥️Trending News Mizuho has set a new price target of $16.00 for Revance Therapeutics ($NASDAQ:RVNC), a biotechnology company focused on [...]
Piper Sandler Lowers Revance Therapeutics’ PT to $42.00
🌧️Trending News Piper Sandler recently announced a reduced price target for Revance Therapeutics ($NASDAQ:RVNC). Revance Therapeutics is a biotechnology company [...]
Revance Therapeutics Intrinsic Value Calculation – REVANCE THERAPEUTICS Reports Q2 2023 Earnings on August 8, 2023
🌥️Earnings Overview On August 8, 2023, REVANCE THERAPEUTICS ($NASDAQ:RVNC) released its financial results for the second quarter of 2023 (ending [...]
Revance Therapeutics Shares Rise 1.75%, Demonstrating Great Upside Potential
Trending News ☀️ Revance Therapeutics ($NASDAQ:RVNC) Inc. has been steadily building momentum in the markets since Friday, May 05, when [...]
Mizuho Raises Price Target of Revance Therapeutics to $33.00 in 2023.
Trending News 🌥️ Mizuho has recently increased the price target of Revance Therapeutics ($NASDAQ:RVNC) for 2023 to $33.00. This is [...]
Barclays Upgrades Revance Therapeutics Price Target to $40.00 for 2023
Trending News 🌥️ Barclays recently upgraded Revance Therapeutics ($NASDAQ:RVNC), setting the price target for 2023 at $40.00. Revance Therapeutics is [...]
